From Protein Science R&D to Therapeutics: Expert Insights (Part 1)
Thomas Laue, Ph.D., Professor, Biochemistry and Molecular Biology; Director, Biomolecular Interaction Technologies Center (BITC), University of New Hampshire
Bjørn Voldborg, MSc, Director, CHO Cell Line Development, The Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark
Andrew Fosberry, Ph.D., Senior Scientific Investigator, Protein and Cellular Sciences, GlaxoSmithKline
Dr. Thomas Laue of University of New Hampshire, Bjørn Voldborg of Technical University of Denmark, and Dr. Andrew Fosberry of GlaxoSmithKline speak to Cambridge Healthtech Institute. They are part of “It’s a Wrap”,
the closing plenary panel discussion representing various R&D stages at PepTalk: The Protein Science Week, January 9-13 in San Diego, California.